Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-7-7
pubmed:abstractText
Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a leukotriene receptor antagonist, are both indicated for the treatment of asthma in adolescent and adult patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0091-6749
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1075-80
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10359889-Administration, Inhalation, pubmed-meshheading:10359889-Administration, Oral, pubmed-meshheading:10359889-Adolescent, pubmed-meshheading:10359889-Adrenergic beta-Agonists, pubmed-meshheading:10359889-Adult, pubmed-meshheading:10359889-Aged, pubmed-meshheading:10359889-Albuterol, pubmed-meshheading:10359889-Asthma, pubmed-meshheading:10359889-Bronchodilator Agents, pubmed-meshheading:10359889-Circadian Rhythm, pubmed-meshheading:10359889-Double-Blind Method, pubmed-meshheading:10359889-Female, pubmed-meshheading:10359889-Humans, pubmed-meshheading:10359889-Leukotriene Antagonists, pubmed-meshheading:10359889-Lung, pubmed-meshheading:10359889-Male, pubmed-meshheading:10359889-Middle Aged, pubmed-meshheading:10359889-Respiratory Function Tests, pubmed-meshheading:10359889-Severity of Illness Index, pubmed-meshheading:10359889-Therapeutic Equivalency, pubmed-meshheading:10359889-Tosyl Compounds
pubmed:year
1999
pubmed:articleTitle
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
pubmed:affiliation
University of Wisconsin-Madison Medical School, Madison, WI, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study